ECHA identifies needs for harmonised classification as vPvM for certain cyclodextrins
In its assessment of regulatory needs on cyclic polysaccharides and their ether and ester derivatives from June 2024, ECHA identified that cyclodextrins are potential vPvM substances. Since there is high release potential to surface waters, soil and ground water due to the use in washing and cleaning products for some of the substances, ECHA proposes to confirm the hazard via harmonised classification (CLH) as vPvM hazard for the substances. The report draws no conclusions regarding possible additional EU regulatory risk management until more clarity is available on how to regulate PMT/vPvM substances.
European Parliament Internal market committee upholds position on Toy Safety Regulation
The new Internal market committee of the European Parliament voted on 5 September to maintain the position of the previous legislature on the Toy Safety Regulation. The interinstitutional negotiations between the Parliament, Council and the European Commission can now start to reach an agreement on the draft act.
Council reduces the scope of the data medicinal products in the common data platform
The Council released its mandate for negotiations with the Parliament on the Regulation establishing a common data platform on chemicals from 17 June, which brings few changes to the original proposal from the Commission. The main amendment to the proposal is the reduction of the scope of the data related to medicinal products that can be included in the common data platform. The Council proposes that only data submitted after the regulation’s entry into force is available on the platform and only data concerning active substances subject to certain regulatory procedures (listed in Annex I part I to the Regulation), with persistent, bio-accumulative and toxic properties or with a known high level of residues in the environment. The Council included a review clause six years after the entry into force of the Regulation to assess whether additional data on medicinal products should be included in the platform.
More information of upcoming actions related to persistent and mobile substances
For more information of regulations under the regulatory watch, as well as a Gantt Chart of the roll out, continuously updated spreadsheet and more information, please visit https://zeropm.eu/regulatory-watch/